MyFinsight
Home
About
Contact
cbio: the income statement
Download
Download image
Net loss and
comprehensive loss
-$24,607K
Interest income
$1,278K
Net loss
-$24,607K
Total other income
(expense)
$1,278K
Loss from operations
-$25,885K
Total operating
expenses
$25,885K
General and
administrative
$5,538K
Research and development
$20,347K
Back
Back
Income Statement
source: myfinsight.com
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)